Product Information

CLINDAMYCIN-BENZOYL PEROX 1-5% is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.7068 per GM under NDC 45802050901. Its NADAC has been published 296 times since Mar 24, 2021.

FDA first approved this application on Sep 21, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLINDAMYCIN-BENZOYL PEROX 1-5%

clindamycin and benzoyl peroxide
$0.7068per GM

NDC

45802050901

Classification

Generic

Dosage Form

KIT

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202440

FDA Approved

9/21/2015

TE Code

AB

On Market Since

2/3/2021

Price Statistics

The NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has been published 296 times since Mar 24, 2021, and over the history we have for it it has declined 57.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7068 per GM
All-time high$1.8527 (May 12, 2021)
All-time low$0.6901 (Jun 17, 2026)
52-week high$0.8776
52-week low$0.6901
Median price$0.8595
Average price$0.9749
Largest weekly change+35.1% (Jan 18, 2023)
Weeks tracked296
Tracking sinceMar 24, 2021

Price History

1W

-2.8%

1M

-4.8%

3M

-3.9%

6M

+1.6%

1Y

-13.6%

3Y

-28.8%

5Y

-60.5%

All

-57.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLINDAMYCIN-BENZOYL PEROX 1-5%?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN-BENZOYL PEROX 1-5%, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.7068 per GM (NDC 45802050901), effective Nov 18, 2026.

How has the price of CLINDAMYCIN-BENZOYL PEROX 1-5% changed over time?

Over the history we have for it, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has declined 57.6%. It has been tracked across 296 weekly CMS publications since Mar 24, 2021.

What are the highest and lowest recorded NADAC prices for CLINDAMYCIN-BENZOYL PEROX 1-5%?

Since Mar 24, 2021, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has ranged from a low of $0.6901 (Jun 17, 2026) to a high of $1.8527 (May 12, 2021), with a median of $0.8595 per GM.

Are there cheaper alternatives to CLINDAMYCIN-BENZOYL PEROX 1-5%?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN-BENZOYL PEROX 1-5%, is $0.5646 per GM — about 20% below CLINDAMYCIN-BENZOYL PEROX 1-5%.

Who manufactures CLINDAMYCIN-BENZOYL PEROX 1-5%?

CLINDAMYCIN-BENZOYL PEROX 1-5% (NDC 45802050901) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.